George Soros’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,800
Closed -$2.01M 224
2023
Q2
$2.01M Buy
+15,800
New +$2.05M 0.03% 154
2018
Q1
Sell
-20,700
Closed -$2.21M 255
2017
Q4
$2.21M Buy
20,700
+18,900
+1,050% +$2.02M 0.05% 137
2017
Q3
$200K Buy
+1,800
New +$192K ﹤0.01% 221
2017
Q2
Sell
-4,500
Closed -$440K 255
2017
Q1
$440K Sell
4,500
-3,900
-46% -$373K 0.01% 177
2016
Q4
$743K Buy
8,400
+6,069
+260% +$552K 0.02% 138
2016
Q3
$225K Buy
+2,331
New +$222K 0.01% 215
2016
Q2
Sell
-202,800
Closed -$17.6M 200
2016
Q1
$17.6M Buy
+202,800
New +$18.1M 0.39% 55
2015
Q3
Sell
-7,200
Closed -$886K 257
2015
Q2
$886K Buy
+7,200
New +$862K 0.01% 213

Other funds holding IBB

George Soros's IBB Position: Q3 2023 in Review

George Soros sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 15,800 shares — an estimated $2.01M sold.

George Soros first reported a position in IBB in Q2 2015 and held it in 8 quarters. The position peaked at $17.6M in Q1 2016. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

  • George Soros reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
  • George Soros sold 15,800 iShares Biotechnology ETF shares in Q3 2023, an estimated $2.01M.
  • George Soros first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 8 quarters.
  • George Soros's iShares Biotechnology ETF position peaked at $17.6M in Q1 2016.
  • 833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Soros Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.